General Practice Doctors in Fort Collins, CO Accepting Medicare

4 General Practice doctors found. Showing 1 - 4

Dr. Venkataperumal R Chandrasekaran, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1006 Robertson St, Fort Collins, CO 80524 Phone: 970-224-1596    Fax: 970-530-1919

Dr. Timothy Scott Roberts, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3702 Automation Way Ste 103, Fort Collins, CO 80525 Phone: 970-224-2985

Dr. Narda Gail Robinson, DO, DVM General Practice Medicare: Not Enrolled in Medicare Practice Location: 519 N Grant Ave, Fort Collins, CO 80521 Phone: 970-443-3588    Fax: 970-297-1275

Dr. Paolo Romero, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 2121 E Harmony Rd, Unit 150, Fort Collins, CO 80528 Phone: 970-493-6337    Fax: 970-493-3528

News Archive

Check and balance for neuron activity provides insight into schizophrenia, seizures

Two genes important for human development and implicated in cancer and schizophrenia also help keep a healthy balance between excitation and inhibition of brain cells, researchers say.

Scientist develop compact, portable sanitizing device for masks and other items

COVID-19 has significantly increased public use of face masks to protect others from the wearer's respiratory droplets as well as the wearer from airborne contaminants.

Education campaign fails to improve guideline adherence in paediatric AOM

Swedish researchers report that overall adherence to treatment guidelines for acute otitis media in children is good, at 70–90%, but that adherence to watchful waiting is poor.

Blog examines implications of synthetic artemisinin production for global health

"This week, PATH and our partners celebrated the official launch of the production line for a new synthetic version of artemisinin, the key ingredient for the gold-standard malaria treatment - one that plays a major role in protecting the lives of children and adults worldwide," PATH President and CEO Steve Davis writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

Read more Medical News

› Verified 7 days ago